Navigation Links
Omthera Pharmaceuticals Announces First Quarter 2013 Financial Results
Date:5/28/2013

ing statements within the meaning of the Private Securities Litigation Reform Act of 1995. This press release contains express or implied forward-looking statements relating to, among other things, the proposed transaction between AstraZeneca and Omthera, Omthera's expectations regarding the filing of its NDA for Epanova, the timing of product approval and commercial launch and management's plans, objectives, and strategies. These statements do not convey historical information, but relate to predicted or potential future events that are based upon management's current expectations. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. In particular, such risks and uncertainties include, but are not limited to, the Company's ability to achieve profitability; the implementation of the Company's corporate strategy; the Company's future financial performance and projected expenditures; the Company's ability to enter into future collaborations with pharmaceutical companies; the Company's product development activities, including the preparation of its NDA for Epanova, as well as to increase capacity and validate the manufacturing process at our suppliers and build inventory for launch; the Company's ability to receive, and the timing of any receipt of, regulatory approvals to develop and commercialize the Company's product candidate; the Company's PDUFA date for Epanova; the Company's ability to protect its intellectual property and operate its business without infringing upon the intellectual property rights of others; the accuracy of the Company's expectations regarding federal, state and foreign regulatory requirements; the therapeutic benefits, effectiveness and safety of Epanova; the accuracy of the Company's estimates of the size and characteristics of the markets that may be addressed by Epanova; the Company's projected markets and growth in markets; the Com
'/>"/>
SOURCE Omthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Covington Advises Omthera Pharmaceuticals on Merger with AstraZeneca
2. Omthera Pharmaceuticals, Inc. Announces Closing of Initial Public Offering
3. Omthera Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering
4. Omthera Pharmaceuticals Presents Data From Analysis Of EVOLVE Trial Showing That Epanova Lowers ApoC-III, A Key Predictor of Cardiovascular Risk
5. Omthera Pharmaceuticals Announces Invitation to Attend Presentation of the Complete Data Sets from its Phase 3 EVOLVE and ESPRIT Clinical Studies
6. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
7. DelMar Pharmaceuticals to Present Clinical Trials Data for VAL-083 Brain Cancer Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
8. Valeant Pharmaceuticals Announces Receipt Of U.S. FDA Complete Response Letter For Efinaconazole
9. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Market Worth $825 Million by 2017
10. Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference
11. Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... CHAPEL HILL, N.C. , May 22, 2015 ... will be hosting its sixth Medical Affairs ... – 12:30PM (EDT) via a virtual roundtable to ... Outcomes Research." Best Practices, Medical Affairs ... for sharing insights about the key challenges they ...
(Date:5/22/2015)... , May 22 2015 /CNW/ - The Taskforce representing ... appreciative of all the hard work that the Minister and ... six months. This program recognizes the needs of the thalidomide ... least $75,000 a year, tax free, with annual adjustments for ... eligible for annual payments of $100,000 based on the severity ...
(Date:5/22/2015)... OAKS, Calif. , May 22, 2015 ... announced the Company has commenced termination of ... of brodalumab with AstraZeneca (LON:AZN, STO:AZN and ... IL-17 inhibitor, is in development for patients ... axial spondyloarthritis.  The decision was based on ...
Breaking Medicine Technology:Best Practices Sixth Medical Affairs Consortium Roundtable to Focus on Health Economics & Outcomes Research 2Amgen to terminate participation in co-development and commercialization of brodalumab 2Amgen to terminate participation in co-development and commercialization of brodalumab 3Amgen to terminate participation in co-development and commercialization of brodalumab 4Amgen to terminate participation in co-development and commercialization of brodalumab 5
... 2011 Reportlinker.com announces that a new market ... Cancer Nucleic Acid Testing ... The report presents an overview of the clinical ... as well as listings of companies developing and ...
... 2011 Devicor™ Medical Products, Inc. (Devicor), ... firm, announced today the completion of its previously announced ... products and related assets from Neoprobe Corporation. ... for the GDS portfolio. Financial terms of the agreement ...
Cached Medicine Technology:Devicor™ Medical Products, Inc. Completes Acquisition of Neoprobe's Gamma Detection Devices 2Devicor™ Medical Products, Inc. Completes Acquisition of Neoprobe's Gamma Detection Devices 3
(Date:5/25/2015)... After the sensational buzz surrounding their past two ... Trivedi Master Wellness™ agrees to hold another ... “Consciousness is Power.” Presently, the Live-Streaming event is scheduled ... routinely allotted time from 10:00pm PST/1:00pm EST to 6:00pm ... to the public and accessible on the web through ...
(Date:5/25/2015)... (PRWEB) May 25, 2015 Decora Preset ... ‘Leviton’ is now available on ‘The Hardware City.’ The product ... has to set a time and the related electronic device ... contacted a representative of the company said, “We are glad ... City.’ Now customers can buy Countdown Timer Switch in just ...
(Date:5/24/2015)... (PRWEB) May 24, 2015 Women's ... about hair loss. Although it is unclear about the ... are environmental factors such as metabolism, nutritional deficiencies, thyroid ... they offer a comprehensive approach to evaluating the metabolic, ... woman, they can help patients find a cause for ...
(Date:5/24/2015)... 24, 2015 Scientists with Cardno ChemRisk, ... air quality compliance issues that may have raised the ... Mesothelioma has just posted an article on the research. ... The group found airborne asbestos levels well above OSHA ... 1984 and 2011. , “Asbestos compliance sampling data associated ...
(Date:5/24/2015)... Viejo, CA (PRWEB) May 24, 2015 ProPin ... use in Final Cut Pro X. Utilize ProPin to pin ... in a given scene. , ProPin allows users to ... completely customizable in FCPX. With on-screen controls, video editors can ... allows users to pin and mark with absolute ease. , Using ...
Breaking Medicine News(10 mins):Health News:Hundreds of People Are Thrilled to Hear that Trivedi Master Wellness™ Promises to Hold Another Workshop in June 2015 2Health News:Hundreds of People Are Thrilled to Hear that Trivedi Master Wellness™ Promises to Hold Another Workshop in June 2015 3Health News:Leviton's Decora 60 Minute Countdown Timer Available On ‘The Hardware City’ 2Health News:Women's Excellence Now Treats Menopausal Hair Loss 2Health News:New Analysis Finds Too Many Employers Ignored OSHA Asbestos Guidelines, According to Surviving Mesothelioma 2Health News:Developers at Pixel Film Studios Release ProPin for Final Cut Pro X. 2
... hospitals and the,Coalition to Protect Florida,s Drivers lauded ... restore no-fault auto insurance, calling it a,"great protection" ... Governor Crist,s signing into law of CS/HB ... Personal Injury Protection (PIP),coverage, will be restored on ...
... levels of protein indicating damage returned to normal ... News) -- Preliminary research suggests that potent AIDS drugs ... infected with HIV. , The findings are based upon ... so it,s not clear exactly what they mean for ...
... Inc.,(NYSE: CAH ), a global provider of products and ... to release first-quarter,results for its fiscal 2008 on Monday, Nov. ... Stock Exchange. The company has scheduled a conference call ... To access the call and corresponding slide,presentation, go to the ...
... Transfer to Healthcare Marketplace -, ATLANTA, Oct. ... community management (BCM) solutions, today announced it,is sponsoring ... Electronic Data Interchange (WEDI) Conference on Health Savings,Accounts ... BizManager,suite and Secure Link solution. The conference is ...
... Once-In-A-Lifetime Opportunity, BOCA RATON, Fla., Oct. 11 ... with American Exhibitions, Inc., is pleased to,announce the ... to its existing,Orlando, Detroit and Rochester installations. ... THE UNIVERSE WITHIN will open at the Science ...
... point to serious shortcomings, some experts say , , THURSDAY, Oct. ... Topps, which billed itself as the leading U.S. maker of ... million pounds of beef due to E. coli ... pounds of a brand of beef patties believed to be ...
Cached Medicine News:Health News:Hospital Coalition Says Governor's No-Fault Bill Signing Provides a 'Great Protection' for Florida Consumers 2Health News:AIDS Drugs May Protect Brain 2Health News:Cardinal Health To Announce First-Quarter Results on November 5 2Health News:Inovis Sponsors ASC X12 Conference, Exhibits BizManager and Secure Link 2Health News:Our Body: The Universe Within Exhibition Announces Four New Exhibits Across The Nation 2Health News:Concerns Rise Over U.S. Food Safety 2Health News:Concerns Rise Over U.S. Food Safety 3Health News:Concerns Rise Over U.S. Food Safety 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: